Human platelets contain forms of factor V in disulfide-linkage with multimerin

 

 Buy Article Permissions and Reprints

Summary

Factor V is an essential cofactor for blood coagulation that circulates in platelets and plasma. Unlike plasma factor V, platelet factorV is stored complexed with the polymeric α-granule protein multimerin. In analyses of human platelet factor V on nonreduced denaturing multimer gels, we identified that approximately 25% was variable in size and migrated larger than single chain factor V, the largest form in plasma. Upon reduction, the unusually large, variably-sized forms of platelet factor V liberated components that comigrated with other forms of platelet factor V, indicating that they contained factor V in interchain disulfide-linkages. With thrombin cleavage, factor Va heavy and light chain domains, but not B-domains, were liberated from the components linked by interchain disulfide bonds, indicating that the single cysteine in the B-domain at position 1085 was the site of disulfide linkage. Since unusually large factor V had a variable size and included forms larger than factor V dimers, the data suggested disulfide-linkage with another platelet protein, possibly multimerin. Immunoprecipitation experiments confirmed that unusually large factor V was associated with multimerin and it remained associated in 0.5 M salt. Moreover, platelets contained a subpopulation of multimerin polymers that resisted dissociation from factor V by denaturing detergent and comigrated with unusually large platelet factor V, before and after thrombin cleavage.The disulfide-linked complexes of multimerin and factor V in platelets, which are cleaved by thrombin to liberate factor Va, could be important for modulating the function of platelet factor V and its delivery onto activated platelets. Factor Va generation and function from unusually large platelet factor V is only speculative at this time.

• References

• 1 Kane WH, Davie EW. Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders. Blood 1988; 71: 539-55.
  PubMedGoogle Scholar
• 2 Mann KG, Kalafatis M. Factor V: a combination of Dr Jekyll and Mr. Hyde. Blood 2003; 101: 20-30.
  CrossrefPubMedGoogle Scholar
• 3 Cui J, O’Shea S, Purkayastha A. et al. Fatal hemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V. Nature 1996; 384: 66-8.
  CrossrefPubMedGoogle Scholar
• 4 Miletich JP, Majerus DW, Majerus PW. Patients with congenital factor V deficiency have decreased factor Xa binding sites on their platelets. J Clin Invest 1978; 62: 824-31.
  CrossrefPubMedGoogle Scholar
• 5 Guasch JF, Cannegieter S, Reitsma PH. et al. Severe coagulation factor V deficiency caused by a 4 bp deletion in the factor V gene. Br J Haematol 1998; 101: 32-9.
  CrossrefPubMedGoogle Scholar
• 6 Chediak J, Ashenhurst JB, Garlick I. et al. Successful management of bleeding in a patient with factor V inhibitor by platelet transfusions. Blood 1980; 56: 835-41.
  PubMedGoogle Scholar
• 7 Borchgrevink CF, Owren PA. The hemostatic effect of normal platelets in hemophilia and factor V deficiency: the importance of clotting factors adsorbed on platelets for normal hemostasis. Acta Med Scand 1961; 170: 375-83.
  PubMedGoogle Scholar
• 8 Nesheim ME, Nichols WL, Cole TL. et al. Isolation and study of an acquired inhibitor of human coagulation factor V. J Clin Invest 1986; 77: 405-15.
  CrossrefPubMedGoogle Scholar
• 9 Cripe LD, Moore KD, Kane WH. Structure of the gene for human coagulation factor V. Biochemistry 1992; 31: 3777-85.
  CrossrefPubMedGoogle Scholar
• 10 Viskup RW, Tracy PB, Mann KG. Isolation of human platelet factor V. Blood 1987; 69: 1188-95.
  PubMedGoogle Scholar
• 11 Gould WR, Silveira JR, Tracy PB. Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V/Va. J Biol Chem 2004; 279: 2383-93.
  CrossrefPubMedGoogle Scholar
• 12 Hayward CPM, Furmaniak-Kazmierczak E, Cieutat A-M. et al. Factor V is complexed with multimerin in resting platelet lysates and colocalizes with multimerin in platelet α-granules. J Biol Chem 1995; 270: 19217-24.
  CrossrefPubMedGoogle Scholar
• 13 Hayward CPM. Multimerin: a bench to bedside chronology of a unique platelet and endothelial cell protein - from discovery to function to abnormalities in disease. Clin Invest Med 1997; 20: 176-87.
  PubMedGoogle Scholar
• 14 Hayward CPM, Weiss HJ, Lages B. et al. The storage defects in grey platelet syndrome and αδ-storage pool deficiency affect α-granule factor V and multimerin storage without altering their proteolytic processing. Br J Haematol 2001; 113: 871-7.
  CrossrefPubMedGoogle Scholar
• 15 Hayward CPM, Rivard GE, Kane WH. et al. An autosomal dominant, qualitative platelet disorder associated with multimerin deficiency, abnormalities in platelet factor V, thrombospondin, von Willebrand factor, and fibrinogen and an epinephrine aggregation defect. Blood 1996; 87: 4967-78.
  PubMedGoogle Scholar
• 16 Hayward CPM, Smith JW, Horsewood P. et al. P-155, a multimeric platelet protein that is expressed on activated platelets. J Biol Chem 1991; 266: 7114-20.
  PubMedGoogle Scholar
• 17 Kahr WHA, Zheng S, Sheth PM. et al. Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase type plasminogen activator. Blood 2001; 98: 257-65.
  CrossrefPubMedGoogle Scholar
• 18 Riddles PW, Blakeley RL, Zerner B. Reassessment of Ellman’s reagent. Methods Enzymol 1983; 91: 49-60.
  PubMedGoogle Scholar
• 19 Srivastava A, Quinn-Allen MA, Kim SW. et al. Soluble phosphatidylserine binds to a single identified site in the C2 domain of human factor Va. Biochemistry 2001; 40: 8246-55.
  CrossrefPubMedGoogle Scholar
• 20 Harlow E, Lane D. Antibodies: A Laboratory Manual. Cold Spring Harbor, Cold Spring Harbor Laboratory. 1988
  PubMedGoogle Scholar
• 21 Horsewood P, Hayward CP, Warkentin TE. et al. Investigation of the mechanisms of monoclonal antibody-induced platelet activation. Blood 1991; 78: 1019-26.
  PubMedGoogle Scholar
• 22 Hayward CPM, Song Z, Zheng S. et al. Multimerin processing by cells with and without pathways for regulated protein secretion. Blood 1999; 94: 1337-47.
  PubMedGoogle Scholar
• 23 Hayward CPM, Warkentin TE, Horsewood P. et al. Multimerin: a series of large, disulfidelinked multimeric proteins within platelets. Blood 1991; 77: 2556-60.
  PubMedGoogle Scholar
• 24 Kane WH, Ichinose A, Hagen FS. et al. Cloning of cDNAs coding for the heavy chain region and connecting region of human factor V, a blood coagulation factor with four types of internal repeats. Biochemistry 1987; 26: 6508-14.
  CrossrefPubMedGoogle Scholar
• 25 Jenny RJ, Pittman DD, Toole JJ. et al. Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci 1987; 84: 4846-50.
  CrossrefPubMedGoogle Scholar
• 26 Mannucci PM. Platelet von Willebrand factor in inherited and acquired bleeding disorders. Proc Natl Acad Sci 1995; 92: 2428-32.
  CrossrefPubMedGoogle Scholar
• 27 Monkovic DD, Tracy PB. Functional characterization of human platelet-released factor V and and its activation by factor Xa and thrombin. J Biol Chem 1990; 265: 17132-40.
  PubMedGoogle Scholar
• 28 Essex DW, Chen K, Swiatkowska M. Localization of protein disulfide isomerase to the external surface platelet membrane. Blood 1995; 86: 2168-73.
  PubMedGoogle Scholar
• 29 Thorelli E, Kaufman RJ, Dahlback B. The Cterminal region of the factor V BD is crucial for the anticoagulant activity of factor V. J Biol Chem 1998; 273: 16140-5.
  CrossrefPubMedGoogle Scholar
• 30 Guinto ER, Esmon CT, Mann KG. et al. The complete cDNA sequence of bovine coagulation factor V. J Biol Chem 1992; 267: 2971-8.
  PubMedGoogle Scholar
• 31 Yang TL, Cui J, Rehumtulla A. et al. The structure and function of murine factor V and its inactivation by protein C. Blood 1998; 91: 4593-9.
  PubMedGoogle Scholar
• 32 Wyshock EG, Stewart GJ, Colman RW. Thrombin-stimulated human platelets express molecular forms of α-granular factor V (FV), which differ from FVa. Thromb Haemost 1994; 72: 947-56.
  Article in Thieme ConnectPubMedGoogle Scholar